US 12383503
Adagrasib solid pharmaceutical compositions
granted A61KA61K31/519A61K9/0053
Quick answer
US patent 12383503 (Adagrasib solid pharmaceutical compositions) held by Mirati Therapeutics, Inc. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/519, A61K9/0053, A61K9/2009, A61K9/2013